Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Point of Care Nano-Technology Inc | 726.9K | 0.0x | --- |
PaxMedica Inc | 761.5K | 0.0x | --- |
Bellerophon Therapeutics Inc | 672.8K | -0.1x | --- |
NovAccess Global Inc | 594.3K | -0.1x | --- |
Capstone Therapeutics Corp | 504.4K | -0.5x | --- |
TC Biopharm (Holdings) PLC | 332.8K | 0.0x | --- |
Point of Care Nano-Technology, Inc. is engaged in developing and commercialization of kits to diagnose illnesses through the testing of human saliva, referred to as the EZ Saliva test kits. The Company is engaged in selling EZ Saliva products to police departments, testing laboratories and private businesses to test for the presence of controlled substances.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $726.9K |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 72.7M |
Point of Care Nano-Technology Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.22 |
Book Value | $-0.04 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.